Clinical Trials Browser

Phase 1/2 × Esophageal Neoplasms × Drug Therapy × Clear all

Esophageal Neoplasms

NCT01843049 2013-04-30

Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer

Phase 1/2 Unknown

40 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT00041808 2005-06-24

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Phase 1/2 Completed

20 enrolled

BreastDermatologicGastrointestinalSarcomaThoracic

Breast Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Gastrointestinal Stromal Tumors

Clinical Trials

Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)

Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver